# A Study That Evaluates the Decrease in Irritation When Using Additional Acne Treatment Products

> **NCT01313728** · PHASE4 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 26 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Dapsone plus Tretinoin Gel
- **DRUG:** Tretinoin Gel

## Key facts

- **NCT ID:** NCT01313728
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2010-12
- **Final completion:** 2011-01
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2012-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01313728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01313728, "A Study That Evaluates the Decrease in Irritation When Using Additional Acne Treatment Products". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01313728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*